Keytruda Qlex

Active Ingredient(s): Pembrolizumab + Berahyaluronidase Alfa-pmph
FDA Approved: * September 19, 2025
Pharm Company: * MERCK SHARP DOHME
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Keytruda Qlex Subcutaneous Injection, Solution

NDC: 0006-3083

Labeler:

Merck Sharp & Dohme LLC

Keytruda Qlex Subcutaneous Injection, Solution

NDC: 0006-5083

Labeler:

Merck Sharp & Dohme LLC

Popular Topics

Keytruda vs Ippy

I just failed Ippy. Now my oncologist wants to start Keytruda 1/16/15. Those of you who have been on Keytruda for awhile...

4 REPLIES

Thyroid cancer and KEYTRUDA

I have stage 4 thyroid cancer which has metastasized to my lungs. Although it is slow growing, the cancer will kill me. ...

28 REPLIES